| 321 |
Dr. Rajesh Dikshit |
Pattern of care and survival studies Breast cancer |
|
Active Enrollment ongoing |
Bio Statistics |
Breast |
| 349 |
Dr. Ashwini Budrukkar |
A randomized trial of concurrent versus sequential Tamoxifen with radiotherapy to assess the extent of pulmonary fibrosis and disease related control and survival in breast cancer patients |
NCT00896155 |
Accrual completed and follow-up ongoing |
Radiation Oncology |
Breast |
| 656 |
Dr. Rajendra Badwe |
A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel versus Weekly Paclitaxel Plus Weekly Carboplatin in Women with Triple Negative Breast Cancer |
CTRI/2012/07/002802 |
Accrual completed and follow-up ongoing |
Surgical Oncology |
Breast |
| 735 |
Dr. Shalaka Joshi |
Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer |
REF/2014/03/006566 |
Accrual completed and follow-up ongoing |
Surgical Oncology |
Breast |
| 902 |
Dr. Rajendra Badwe |
Randomized controlled trial to assess blockade of voltage gated sodium channels during surgery in operable breast cancer |
CTRI/2014/11/005228 |
Accrual completed and follow-up ongoing |
Surgical Oncology |
Breast |
| 982 |
Dr. Rajendra Badwe |
A Phase III Double Blind Randomized Placebo Controlled study of Trastuzumab as Short Duration Preoperative Therapy in patients with HER2-neu Positive Operable Breast Cancer |
CTRI/2013/12/004263 |
Active Enrollment ongoing |
Surgical Oncology |
Breast |
| 1074 |
Dr. Rajendra Badwe |
A Randomized controlled study to evaluate the role of hydroxy-progesterone in prevention of chemotherapy induced neurotoxicity in women with breast cancer |
CTRI/2015/11/006381 |
Data Analysis ongoing |
Surgical Oncology |
Breast |
| 1216 |
Dr. Sudeep Gupta |
Breast Cancer Registry to collate data on epidemiology and treatment patterns & outcomes of breast cancer in India |
CTRI/2014/09/004972 |
Analysis Ongoing |
Medical Oncology |
Breast |
| 1348 |
Dr. Shalaka Joshi |
To assess the cosmetic outcome in patients undergoing breast conservation surgery (BCS) with or without deep suture approximation of the primary surgical cavity |
REF/2016/12/012792 |
Accrual completed and follow-up ongoing |
Surgical Oncology |
Breast |
| 1442 |
Dr. Sabita Jiwnani |
Feasibility and implications of thoracoscopic dissection of internal mammary nodes in central and inner quadrant breast cancer |
|
Data Analysis ongoing |
Surgical Oncology |
Breast |
| 1602 |
Dr. Tabassum Wadasadawala |
Post-Mastectomy Radiation Therapy in High Risk, Node Negative women with Early Breast Cancer (PMRT-NNBC) |
CTRI/2016/12/007532 |
Active enrollment ongoing |
Radiation Oncology |
Breast |
| 1607 |
Dr. Venkatesh Rangarajan |
NIS expression detection in metastatic breast cancer with 131I NaI |
|
Analysis Ongoing |
Nuclear Medicine |
Breast |
| 1633 |
Dr. Rajendra Badwe |
Biological effect of low and high dose radiation exposure on human peripheral blood mononuclear cells and tumour tissues of cancer patients: a prospective in-vivo study |
CTRI/2017/11/010566 |
Data Analysis ongoing |
Surgical Oncology |
Breast |
| 1683 |
Dr. Tabassum Wadasadawala |
Randomized trial of effect of two fractionation schedules of Adjuvant Radiation following Immediate Autologous Breast Reconstruction (ARIA-BR) on Toxicity and Patient Reported Outcome Measures. |
CTRI/2017/01/007745 |
Accrual completed and intervention ongoing |
Radiation Oncology |
Breast |
| 1722 |
Dr. Sushmita Rath |
Pregnancy Associated Cancer (PAC) Registry to collate data on epidemiology and treatment patterns & outcomes.” |
CTRI/2017/02/007907 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 1784 |
Dr. Rajiv Sarin |
A prospective COhort study of breast cancer patients with New bone metastases to estimate QUality of life, health Economics &Risk of skeletal complications (CONQUER) |
CTRI/2018/03/012317 |
Active Enrollment ongoing |
Radiation Oncology |
Breast |
| 1795 |
Dr. Sushmita Rath |
Protocol No. - I3Y-CR-JPBQ : A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare NSAI plus Abemaciclib, a CDK4 and CDK6 Inhibitor, or plus Placebo and to Compare Fulvestrant plus Abemaciclib or plus Placebo in Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Loco regionally Recurrent or Metastatic Breast Cancer |
CTRI/2017/01/007695 |
Active accrual and intervention ongoing |
Medical Oncology |
Breast |
| 1912 |
Dr. Bhavika Kothari |
A randomized controlled trial to evaluate the safety of breast conserving surgery post neo-adjuvant therapy locally advanced breast cancer. |
CTRI/2018/05/014158 |
Active Enrollment ongoing |
Surgical Oncology |
Breast |
| 1965 |
Dr. Sudeep Gupta |
Pilot study to evaluate the biodistribution & dosimetry of 177Lu - Trastuzumab in HER2 receptor positive metastatic breast carcinoma and its toxicity & efficacy profile |
CTRI/2018/09/015755 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 1972 |
Dr. Shalaka Joshi |
CONcurrent versus SEQuential Chemo-Endocrine therapy in ER positive and HER2 negative non-metastatic breast cancer (CONSEQuenCE) |
CTRI/2018/09/015643 |
Active Enrollment ongoing |
Surgical Oncology |
Breast |
| 2024 |
Dr. Sudeep Gupta |
Protocol No. - I3Y-MC-JPCF : A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer (MonarchE) |
CTRI/2017/10/010017 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Breast |
| 3058 |
Ms. Shabina Siddique |
Study to assess obesity as defined by Waist Hip Ratio (WHR) and Body Mass Index in women with recently diagnosed breast cancer. |
REF/2019/06/026368 |
Data Analysis ongoing |
Surgical Oncology |
Breast |
| 3112 |
Dr. Sudeep Gupta |
Protocol No. - 0063-17 : A global, multicenter, three arms, open-label randomized study to evaluate the efficacy and safety of Nanosomal Docetaxel Lipid Suspension compared to Taxotere® (Docetaxel Injection Concentrate) in triple-negative breast cancer patients with locally advanced or metastatic breast cancer after failure to prior chemotherapy. |
CTRI/2018/06/014390 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Breast |
| 3170 |
Dr. Rima Pathak |
A study to evaluate the incidence and factors that predict the incidence of brain metastasis in patients with Her2 neu positive and Triple Negative Breast Cancer |
|
Case review/sample review ongoing (audit studies) |
Radiation Oncology |
Breast |
| 3175 |
Dr. Tanuja Shet |
Androgen blockade - Is this the missing link between mucinous micro-papillary carcinoma and micro-papillary carcinoma of breast. |
|
Active Enrollment ongoing |
Pathology |
Breast |
| 3177 |
Dr. Rajiv Sarin |
A Prospective Randomised trial to assess the clinical utility of TMH Mini Quality of Life (TMQ) questionnaire |
CTRI/2019/12/022442 |
Data Analysis ongoing |
Radiation Oncology |
Breast |
| 3198 |
Dr. Anbarasan S. |
Retrospective study of demographics, pattern of care and outcome of TNBC patients from a tertiary care cancer centre In India. |
|
Active enrollment ongoing |
Medical Oncology |
Breast |
| 3210 |
Dr. Sheela Sawant |
Prevalence of cardiovascular diseases in long term Breast Cancer survivors |
|
Active Enrollment ongoing |
General Medicine |
Breast |
| 3228 |
Dr. Omshree Shetty |
Establishing an in house, cost effective, TMH Predict gene panel for Prognosis and Prediction in Breast Cancer Patients subjected to adjuvant therapy. |
|
Data Analysis ongoing |
Pathology |
Breast |
| 3302 |
Dr. Rajesh Dikshit |
Development of breast cancer risk prediction model using lifestyle factors and polygenic risk score in Indian population. |
CTRI/2019/10/021652 |
Active Enrollment ongoing |
Centre For Cancer Epidemiology |
Breast |
| 3303 |
Dr. Rima Pathak |
Can knowledge based planning improve the efficiency and consistency of spine stereotactic body radiation therapy? |
|
Case review/sample review ongoing (audit studies) |
Radiation Oncology |
Breast |
| 3304 |
Dr. Rima Pathak |
Can knowledge based planning improve in efficiency and consistency of radiation therapy treatment planning in breast cancer patients? |
|
Active Enrollment ongoing |
Radiation Oncology |
Breast |
| 3367 |
Dr. Shalaka Joshi |
Role of toll-like receptors and TLR agonists in modulating response to chemotherapy in TNBC patients |
CTRI/2020/03/023958 |
Active Enrollment ongoing |
Surgical Oncology |
Breast |
| 3399 |
Dr. Vinay Shankhdhar |
A prospective pilot study to evaluate the success of LYMPHA (Lymphatic Microsurgical Preventive Healing Approach) in women undergoing Axillary dissection for breast cancer |
CTRI/2020/03/024383 |
Data Analysis ongoing |
Surgical Oncology |
Breast |
| 3407 |
Dr. Tabassum Wadasadawala |
Impact of Tumor Bed Boost Technique on Toxicity and Aesthetic Outcomes after Breast Conservation Therapy: A Prospective Longitudinal Study |
CTRI/2020/01/022871 |
Accrual completed and follow-up ongoing |
Radiation Oncology |
Breast |
| 3428 |
Dr. Bhavika Kothari |
A randomized controlled trial to Assess the incidence of lymphedema in women with breast cancer undergoing Sentinel lymph node biopsy or Low axillary sampling. (AiSLe) |
CTRI/2020/04/024460 |
Active enrollment ongoing |
Surgical Oncology |
Breast |
| 3437 |
Dr. Omshree Shetty |
Epithelial-mesenchymal transition (EMT) and Breast Cancer Stemness: Defining the role of OVOL and ACTN4 in cross talk |
|
Active Enrollment ongoing |
Pathology |
Breast |
| 3583 |
Dr. Rajiv Sarin |
Impact of COVID-19 pandemic on Breast Cancer management in a Tertiary Cancer Care Centre: A Case Control Study |
CTRI/2020/11/028969 |
Accrual completed and follow-up ongoing |
Radiation Oncology |
Breast |
| 3650 |
Dr. Anbarasan S. |
Randomized multi-centric trial of Oral Metronomic Maintenance Therapy (OMMT) vs Capecitabine (Cape) maintenance in newly diagnosed, locally advanced and/or node positive, non-metastatic triple negative breast cancer (TNBC) patients after the completion of standard therapy along with an exploratory study to assess if circulating tumor DNA (ctDNA) and/or circulating tumor cells (CTCs) can be used as a biomarker to predict the probability of recurrence |
CTRI/2022/12/047995 |
Not started/Not initiated |
Medical Oncology |
Breast |
| 3675 |
Dr. Prabhat Bhargava |
Retrospective and prospective analysis of microinvasive breast cancer: clinicopathological features, treatment and outcome |
CTRI/2021/07/034916 |
Active accrual and intervention ongoing |
Medical Oncology |
Breast |
| 3708 |
Dr. Sudeep Gupta |
Protocol No. - D967JC00001 : A Phase 1b/2 Multicentre, Open-label, Modular, Dose-finding and Dose-expansion Study to Explore the Safety, Tolerability, and Anti-tumour Activity of Trastuzumab Deruxtecan (T-DXd) in Combination with other Anti-cancer Agents in Patients with HER2-positive Metastatic Breast Cancer (DESTINY-Breast07) |
CTRI/2021/03/031928 |
Accrual completed and intervention ongoing |
Medical Oncology |
Breast |
| 3715 |
Dr. Tabassum Wadasadawala |
PROspecTive Study on the use of gEriatriC assessment Tools for validation of 1-year mortality in breast cancer patients 65 years and older (PROTECT)_x000D_\n |
CTRI/2021/07/034792 |
Accrual completed and intervention ongoing |
Radiation Oncology |
Breast |
| 3716 |
Dr. Prabhat Bhargava |
Avoiding prophylactic growth factors during paclitaxel phase of dose dense adjuvant chemotherapy in breast cancer |
CTRI/2022/03/041308 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 3734 |
Dr. Tabassum Wadasadawala |
Assessment of the Breast Cosmesis using Deep neural networks: an exploratory study (ABCD) |
NCT05450016 |
Active Enrollment ongoing |
Radiation Oncology |
Breast |
| 3740 |
Dr. Shalaka Joshi |
Pilot study for measurement of intra-tumoral interstitial fluid pressure in various cancers |
CTRI/2021/08/035470 |
Active Enrollment ongoing |
Surgical Oncology |
Breast |
| 3784 |
Dr. Gauravi Mishra |
Acceptability, Feasibility and Validity of Clinical Breast Examination by Medical Tactile Examiners as Community Based Outreach Program in Different Locations of India. |
CTRI registration is in proces |
Not started/Not initiated |
Preventive Oncology |
Breast |
| 3799 |
Dr. Rima Pathak |
Impact of on-demand training & audio-visual aids to improve referral rates for genetic counselling and/ testing at a tertiary cancer centre (Mainstreaming Study) |
CTRI/2022/05/042558 |
Active Enrollment ongoing |
Radiation Oncology |
Breast |
| 3809 |
Dr. Shalaka Joshi |
An open label, phase 3 randomized trial to evaluate the role of axillary conservation surgery in breast cancer patients post-neoadjuvant chemotherapy. Short title- Post-chemotherapy Axillary Conservation Surgery (PACS) |
CTRI/2022/07/044461 |
Active accrual and intervention ongoing |
Surgical Oncology |
Breast |
| 3852 |
Dr. Sudeep Gupta |
Protocol No. - WO42633 : Protocol No. - WO42633 : A Phase III, randomized, double-blind,placebo-controlled clinical trial toevaluate the efficacy and safety ofadjuvant atezolizumab or placebo and trastuzumab emtansine forher2-positive breast cancer at high riskof recurrence following preoperativetherapy (ASTEFANIA STUDY)._x000D_\n_x000D_\n |
CTRI/2021/08/035911 |
Accrual completed and intervention ongoing |
Medical Oncology |
Breast |
| 3877 |
Dr. Sudeep Gupta |
Protocol No. - GO42784 : A Phase III, Randomized, Open-Label, Multicenter Study Evaluating The Efficacy And Safety Of Adjuvant Giredestrant Compared With Physician's Choice Of Adjuvant Endocrine Monotherapy In Patients With Estrogen Receptor-Positive, Her2-Negative Early Breast Cancer |
CTRI/2022/01/039625 |
Accrual completed and intervention ongoing |
Medical Oncology |
Breast |
| 3888 |
Dr. Rajiv Sarin |
Developing a 3D-printed Humanoid Phantom for Breast Cancer Radiotherapy Dosimetry and Quality Assurance |
|
Approved |
Radiation Oncology |
Breast |
| 3894 |
Dr. Revathy Krishnamurthy |
Pilot testing of the Bangla translation of the Tata Memorial Centre Mini Quality of Life Questionnaire (TMQ - Bangla) developed for use in routine oncology practice in India |
CTRI/2022/02/040246 |
Active Enrollment ongoing |
Radiation Oncology |
Breast |
| 3915 |
Dr. Sudeep Gupta |
ICGA: Indian Cancer Genome ATLAS |
CTRI/2022/09/045570 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 3927 |
Dr. Sudeep Gupta |
Identifying potentially metastatic cells in primary tissue by identifying specific proteins associated with these phenotypes using an antibody library based screening of TNBC. |
CTRI/2022/10/046300 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 3970 |
Dr. Anbarasan S. |
A Pilot Launch of the Oncoshot platform (an online platform for Oncology Clinical Trial matching & other treatment related services) for Cancer Patients, Cancer Hospitals, Oncologists, Pharmaceutical companies & CROs, in the Indian oncology landscape. |
|
Not started/Not initiated |
Medical Oncology |
Breast |
| 3996 |
Dr. Ayushi Sahay |
Concordance of Biomarker Status in Invasive Breast Carcinoma on Re-evaluation- A Retrospective Audit |
|
Publication activities ongoing |
Pathology |
Breast |
| 4008 |
Dr. Prabhat Bhargava |
Protocol No. - CBYL719CIN01 : CBYL719CIN01 ALPelisib INdia Safety STudy (ALPINIST): A Phase IV, prospective, multicenter, open-label, non-comparative, interventional study to assess the safety of alpelisib plus fulvestrant, in men and post-menopausal women with HR- positive, HER2-negative, advanced or metastatic Breast Cancer (ABC or MBC) with a PIK3CA mutation, whose disease has progressed on or after endocrine based treatment. |
CTRI/2022/04/042205 |
Data Analysis ongoing |
Medical Oncology |
Breast |
| 4054 |
Dr. Anuradha Daptardar |
To evaluate the effectiveness of hybrid bandages (Thonic fast and go) in the management of Lymphedema (HY- LYMPH study) |
CTRI/2023/03/050290 |
Active Enrollment ongoing |
Physiotherapy |
Breast |
| 4055 |
Dr. Sangeeta Desai |
Validation of quantitative image analysis (QIA) tools for tissue biomarkers in breast cancer |
|
Approved |
Pathology |
Breast |
| 4069 |
Dr. Rajiv Sarin |
Clinico-radiological presentation, diagnostic dilemmas, management, and clinical outcomes in breast cancer patients with juxta-regional nodal metastasis |
|
Accrual completed and follow-up ongoing |
Radiation Oncology |
Breast |
| 4071 |
Dr. Palak Popat |
Morphological Signature Of Brain Metastases As A Surrogate marker Of Molecular Profile Of Primary Breast Cancer And To Assess Its Feasibility As A Predictive Marker For Prognosis Of Patients With Neuroparenchymal Metastases From Breast Cancer._x000D_\n |
|
Approved |
Radio-diagnosis |
Breast |
| 4131 |
Dr. Tabassum Wadasadawala |
Phase III randomized controlled trial of sequential chemotherapy and radiotherapy versus concurrent chemoradiotherapy in adjuvant treatment of breast cancer |
CTRI/2023/06/054280 |
Active accrual and intervention ongoing |
Radiation Oncology |
Breast |
| 4144 |
Dr. Sudeep Gupta |
WO43571 A Phase III, Randomized, Open-Label Study Evaluating The Efficacy And Safety Of Giredestrant In Combination With Phesgo Versus Phesgo After Induction Therapy With PHESGO + Taxane In Patients With Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced Or Metastatic Breast Cancer |
CTRI/2023/08/056489 |
Accrual completed and intervention ongoing |
Medical Oncology |
Breast |
| 4178 |
Dr. Sudeep Gupta |
J2J-MC-JZLH EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence. |
CTRI/2023/05/052375 |
Accrual completed and intervention ongoing |
Medical Oncology |
Breast |
| 4182 |
Dr. Sudeep Gupta |
C4891001 A PHASE 3, RANDOMIZED, OPEN-LABEL, MULTICENTER TRIAL OF ARV-471 (PF-07850327) VS FULVESTRANT IN PARTICIPANTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR ENDOCRINE BASED TREATMENT FOR ADVANCED DISEASE (VERITAC-2). |
CTRI/2023/05/052598 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Breast |
| 4183 |
Dr. Purvi Haria |
Role of Shear wave elastography in assessment of response to neoadjuvant chemotherapy (NACT) in breast cancer patients. |
CTRI/2024/03/063796 |
Active accrual and intervention ongoing |
Radio-diagnosis |
Breast |
| 4222 |
Dr. Rajendra Badwe |
PRe-operative ChemoTherapy versus Surgery first with peri-operative interventions in Early triple negative and HER2 enriched breast - an open label, phase 3, randomized controlled trial (PRaCTiSE) |
CTRI/2024/02/063118 |
Active enrollment ongoing |
Surgical Oncology |
Breast |
| 4226 |
Dr. Tabassum Wadasadawala |
Protocol No. - CCR5119 : Randomised phase II trial testing efficacy of intra-tumoural hydrogen peroxide as a radiation sensitiser in patients with locally advanced/recurrent breast cancer |
CTRI/2022/02/040331 |
Active accrual and intervention ongoing |
Radiation Oncology |
Breast |
| 4232 |
Dr. Tabassum Wadasadawala |
Burden of financial toxicity in breast cancer patients treated with curative intent: a multinational study from low-middle income countries (FIT study) |
CTRI/2024/01/062071 |
Active Enrollment ongoing |
Radiation Oncology |
Breast |
| 4243 |
Dr. Omshree Shetty |
Tumor Microbiome in Triple Negative Breast Cancers in India |
|
Not started/Not initiated |
Pathology |
Breast |
| 4248 |
Dr. Sudeep Gupta |
RP6530-2301 - A Phase II, Multi-center, Single-arm, Open-label Study to Assess the Efficacy and Safety of Tenalisib, a PI3K δ/γ, and SIK3 Inhibitor, in Patients with Metastatic Triple Negative Breast Cancer (TNBC) |
CTRI/2024/01/061635 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 4249 |
Dr. Palak Popat |
Role of shear wave elastography as a part of Multiparametric ultrasonography in triaging breast lesions for need of biopsy. |
|
Active Enrollment ongoing |
Radio-diagnosis |
Breast |
| 4254 |
Dr. Prarthna Shah |
Addressing diagnostic modalities for identifying HER2 low and ultra-low classes in breast cancer. |
|
Active Enrollment ongoing |
Pathology |
Breast |
| 4255 |
Dr. Ayushi Sahay |
Evaluation of Osteopontin (OPN) Variants in Premalignant Breast Lesions |
|
Active Enrollment ongoing |
Pathology |
Breast |
| 4273 |
Dr. Sudeep Gupta |
Impact of HER2 Low on demographic profile and survival outcomes of Hormone positive breast cancer (HER- IMPACT) |
CTRI/2024/01/061482 |
Data Analysis ongoing |
Medical Oncology |
Breast |
| 4300 |
Dr. Sudeep Gupta |
Evaluation of DSC-3 expression in triple negative breast cancer (TNBC) |
CTRI/2024/04/064982 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 4301 |
Dr. Sudeep Gupta |
Real life evidence of Tab Ribociclib for Safety and Efficacy in a tertiary care center( RERISE study). |
CTRI/2024/01/061744 |
Case review/sample review ongoing (audit studies) |
Medical Oncology |
Breast |
| 4302 |
Dr. Prabhat Bhargava |
A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy with Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients with ER+/HER2- Early Breast Cancer and an Intermediate or High Risk of Recurrence Who Have Completed Definitive Locoregional Therapy and at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Without Disease Recurrence (CAMBRIA-1). |
CTRI/2024/09/074115 |
Ongoing |
Medical Oncology |
Breast |
| 4338 |
Dr. Shalaka Joshi |
Surgical Cosmesis And patient reported outcome measures in patients who have undergone tRansposition flap reconstruction after BCS (SCAR) |
CTRI/2024/05/066667 |
Active enrollment ongoing |
Surgical Oncology |
Breast |
| 4348 |
Dr. Tabassum Wadasadawala |
A RETROSPECTIVE AUDIT OF PATTERNS OF BREAST CANCER RECURRENCE IN LOW-RISK POST MENOPAUSAL WOMEN |
|
Case review/sample review ongoing (audit studies) |
Radiation Oncology |
Breast |
| 4350 |
Dr. Sohan Solanki |
Comparison of effect of Amisulpride and Dexamethasone with Ondansetron and Dexamethasone for postoperative nausea and vomiting after post-chemotherapy breast cancer surgeries: A Randomised Active Controlled Double Blind Study |
CTRI/2024/04/066189 |
Active Enrollment ongoing |
Anaesthesia |
Breast |
| 4364 |
Dr. Shalaka Joshi |
A prospective analysis of postoperative surgical site infection and factors affecting it, including the preoperative HbA1C and fasting blood glucose level, in patients undergoing elective breast oncological surgery. |
CTRI/2024/06/068383 |
Data Analysis ongoing |
Surgical Oncology |
Breast |
| 4375 |
Dr. Vikram Gota |
Study of association between prakriti and outcomes of early and locally advanced breast cancer. |
CTRI/2025/02/079984 |
Approved |
Clinical Pharmacology |
Breast |
| 4389 |
Dr. Sushmita Rath |
A phase II double-arm study of the switch of Endocrine therapy with the change of CDK4/6 inhibitor vs. switch of endocrine therapy alone as second-line and beyond in ER-positive breast cancer patients (SECURE study). |
CTRI/2024/06/068274 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 4409 |
Dr. Sudeep Gupta |
BIO-PERTUZ-301 A Multicenter, Double-blind, Randomized, Parallel-group, Phase 3 Study to Compare the Efficacy and Safety of the Proposed Biosimilar PERT-IJS and EU-Perjeta® along with Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Patients with Hormone Receptor Negative (HR-ve) Human Epidermal Growth Factor Receptor 2 (HER2)-positive Early Stage or Locally Advanced Breast Cancer. |
CTRI/2024/02/063261 |
Active Enrollment ongoing |
Medical Oncology |
Breast |
| 4420 |
Dr. Revathy Krishnamurthy |
Partial breast re-irradiation using ultra hypofractionation (PRESERVE): Phase 2 multi-institutional study |
|
Approved |
Radiation Oncology |
Breast |
| 4466 |
Dr. Palak Popat |
Automated Breast Ultrasound- Future in breast imaging |
Not applicable |
Data Analysis ongoing |
Radio-diagnosis |
Breast |
| 4473 |
Dr. Ayushi Sahay |
Histopathological Spectrum of Male Breast Cancer: A Retrospective Audit |
|
Active Enrollment ongoing |
Pathology |
Breast |
| 4475 |
Dr. Sudeep Gupta |
C4391022 AN INTERVENTIONAL, OPEN-LABEL, RANDOMIZED, MULTICENTER PHASE 2 STUDY OF PF-07220060 PLUS FULVESTRANT COMPARED TO INVESTIGATOR'S CHOICE OF THERAPY IN PARTICIPANTS ATLEAST 18 YEARS OF AGE WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED/METASTATIC BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR CDK 4/6 INHIBITOR BASED THERAPY (FOURLIGHT-1). |
CTRI/2024/07/069956 |
Accrual completed and intervention ongoing |
Medical Oncology |
Breast |
| 4487 |
Dr. Palak Popat |
A PRospective evaluation of impact of additional Imaging modalities in Surgical Management and outcome in Treatment naive breast Cancer patients_x000D_\n_x000D_\nPRiISM |
|
Approved |
Radio-diagnosis |
Breast |
| 4494 |
Dr. Rajiv Sarin |
Audit of Incidence and factors predicting symptomatic radiation necrosis in breast cancer patients treated using Stereotactic Radiosurgery for brain metastasis (SRS-RN STUDY) |
|
Approved |
Radiation Oncology |
Breast |
| 4538 |
Dr. Tabassum Wadasadawala |
Young Women with Breast Cancer: Assessing the unmet needs longitudinally |
CTRI/2024/11/076743 |
Active Enrollment ongoing |
Radiation Oncology |
Breast |
| 4546 |
Dr. Anbarasan S. |
D9673R00037 A Multicenter, Retrospective, Noninterventional Study to Determine the Prevalence of HER2-low, Clinical Characteristics, Treatment Patterns, and Associated Outcomes in Patients Previously Identified With HER2 negative Locally-advanced or Metastatic Breast Cancer Who Progressed on Systemic Anticancer Therapy. (iRetroBC-HER2L Study). |
CTRI/2024/03/063553 |
Approved |
Medical Oncology |
Breast |
| 4562 |
Dr. George John |
Randomized, double-blind, placebo-controlled study of oral duloxetine in prevention of acute pain syndrome in patients receiving paclitaxel _x000D_\n_x000D_\n |
CTRI/2024/10/075636 |
Accrual completed and intervention ongoing |
Medical Oncology |
Breast |
| 4567 |
Dr. Sudeep Gupta |
MK-2870-010 An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician's Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer. |
CTRI/2024/11/076326 |
Approved |
Medical Oncology |
Breast |
| 4568 |
Dr. Sushmita Rath |
Investigate the Role of Tumor Microbiome on Metastatic Triple-Negative Breast Cancer Progression |
CTRI/2025/08/092895 |
Approved |
Medical Oncology |
Breast |
| 4577 |
Dr. Sudeep Gupta |
A case series to report CDK4/6 induced Vitiligo. |
CTRI/2025/01/079700 |
Study Initiated and Recruitment Started |
Medical Oncology |
Breast |
| 4628 |
Dr. Sudeep Gupta |
D9673L00012 A PROSPECTIVE, MULTI-CENTER, PHASE 4, SINGLE ARM STUDY TO ASSESS THE SAFETY OF TRASTUZUMAB DERUXTECAN, AN ANTI-HER2-ANTIBODY DRUG CONJUGATE IN INDIAN PATIENTS WITH UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER WHO HAVE RECEIVED A PRIOR ANTI-HER2-BASED REGIMEN. |
CTRI/2024/07/070945 |
Approved |
Medical Oncology |
Breast |
| 4637 |
Dr. Shalaka Joshi |
patient reported outcome measures in breast cancer surgery (TROUSSEAU) |
CTRI/2025/04/103117 |
Approved |
Surgical Oncology |
Breast |
| 4639 |
Dr. Tabassum Wadasadawala |
Mammography based Assessment of Radiological incidence of fat necrosis & Volumetric EvoLution of Breast after Breast Conservation Therapy and Reconstruction (MARVEL) |
|
Approved |
Radiation Oncology |
Breast |
| 4647 |
Dr. Sudeep Gupta |
C4391024 An Interventional, Open-Label, Randomized, Multicenter Phase 3 Study Of PF-07220060 Plus Letrozole Compared To CDK4/6 Inhibitor Plus Letrozole In Participants Over 18 Years Of Age With Hormone Receptor (HR)-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Who Have Not Received Any Prior Systemic Anticancer Treatment For Advanced/Metastatic Disease (Fourlight-3). |
CTRI/2025/04/084336 |
Approved |
Medical Oncology |
Breast |
| 4686 |
Dr. Sneha Shah |
Pilot study to evaluate the role of FAPI in lobular variant of breast cancer. |
|
Approved |
Nuclear Medicine |
Breast |
| 4746 |
Dr. Shalaka Joshi |
Validation of dual tracer Sentinel Lymph node biopsy in patients with non-metastatic in-breast tumour recurrence undergoing Re-surgery and study of lymphatic drainage pathways (SLR study) |
|
Approved |
Surgical Oncology |
Breast |
| 4751 |
Dr. Tabassum Wadasadawala |
A pilot study of assessing surgical morbidity of preoperative radiotherapy in women undergoing whole breast reconstruction (SUPER-RT) |
CTRI/2025/07/090444 |
Approved |
Radiation Oncology |
Breast |
| 4814 |
Dr. Prabhat Bhargava |
A phase IIIb study to characterize the efficacy and safety of Adjuvant ribociclib plus endocrine therapy in a close-to-clinical practice patient population with HR+ HER2− early breast cancer (Adjuvant WIDER) |
CTRI/2025/08/092444 |
Ongoing |
Medical Oncology |
Breast |
| 4821 |
Dr. Anuradha Mehta |
A placebo-controlled, randomised phase III trial comparing capecitabine with megestrol acetate or capecitabine with placebo in hormone receptor-positive and HER2-negative metastatic breast cancer (CAMEO STUDY)_x000D_\n_x000D_\n |
|
Approved |
Medical Oncology |
Breast |
| 4858 |
Dr. Tanuja Shet |
Molecular Profiling of Cellular Breast Fibroepithelial Lesions in children and young adults |
|
Approved |
Pathology |
Breast |
| 4929 |
Ms. Mamta Gurav |
Establishing a Molecular and Microenvironmental Basis of Reversed cell Polarity in Breast Cancer |
|
Approved |
Pathology |
Breast |
| 4935 |
Dr. C. S. Pramesh |
Developing cost accounting framework for Tata Memorial Hospital- A pilot study on costing of breast cancer care |
|
Approved |
Surgical Oncology |
Breast |
| 4977 |
Dr. Sudeep Gupta |
Deep Learning on Histopathological Images for Risk Stratification in Indian Breast Cancer Patients. |
|
Approved |
Medical Oncology |
Breast |
| 5012 |
Dr. Sneha Shah |
Retrospective evaluation of impact of Ga 68 FAPI PETCT in lobular variant of breast cancer. |
|
Approved |
Nuclear Medicine |
Breast |